K992061 · Lasermed, Inc. · GEX · Jul 30, 1999 · General, Plastic Surgery
Device Facts
Record ID
K992061
Device Name
PULSTAR
Applicant
Lasermed, Inc.
Product Code
GEX · General, Plastic Surgery
Decision Date
Jul 30, 1999
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 878.4810
Device Class
Class 2
Attributes
Therapeutic
Intended Use
Light source for the purpose of curing light activated dental composites and activating dental bleaching agents.
Device Story
PULSTAR is a light source device used in dental clinics by dental professionals. It functions by emitting light to cure light-activated dental composites and activate dental bleaching agents. The device serves as an auxiliary tool during restorative or cosmetic dental procedures to facilitate the hardening of materials or the chemical activation of whitening agents. It is operated by dentists or dental staff to improve procedural efficiency and patient outcomes in dental care settings.
Clinical Evidence
Bench testing only.
Technological Characteristics
Light source device for dental applications. Specific materials, energy source, and dimensions are not detailed in the provided documentation.
Indications for Use
Indicated for curing light-activated dental composites and activating dental bleaching agents in dental patients.
Regulatory Classification
Identification
(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
K992728 — SPRING POWERLITE 2000 · Spring Health Products, Inc. · Sep 29, 1999
K974369 — APOLLO 9500 · Ion Laser Technology · Jan 6, 1998
Submission Summary (Full Text)
{0}------------------------------------------------
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged around the upper portion of the circle. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 30 1999
Mr. Calvin D. Ostler Vice President, Product Development LaserMed, Inc. 8050 South 1300 West West Jordan, Utah 84088
Re: K992061 Trade Name: PULSTARTM Regulatory Class: II Product Code: GEX Dated: June 14, 1999 Received: June 18, 1999
Dear Mr. Ostler:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
## Page 2 – Mr. Calvin D. Ostler
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Director
Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(K) Number (if known):
Device Name: PULSTAR™
Indications for Use: "Light source for the purpose of curing light activated dental composites and activating dental bleaching agents."
## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Piaoleps
(Division Sign-Off)
Division of General Restorative Devices
510(k) Number. K992061
Prescription Use D (per 21 CFR 801.100)
OR
Over The Counter Use
(Optional Format 1-2-96)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.